Common use of Payment for Sponsor Drug or Comparator Drug Clause in Contracts

Payment for Sponsor Drug or Comparator Drug. Institution and Principal Investigator will not charge a Trial Subject or third-party payer for Sponsor Drug or Comparator Drug or for any services reimbursed by Sponsor or its designee under this Agreement. 4.5.

Payment for Sponsor Drug or Comparator Drug. Institution and Principal Investigator will not charge a Trial Subject or third-party payer for Sponsor Drug or Comparator Drug or for any services reimbursed by Sponsor or its designee under this Agreement. 4.5. Platba za hodnocený léčivý přípravek nebo srovnávací lék Zdravotnické zařízení a hlavní zkoušející nebudou subjektům klinického hodnocení ani plátcům třetích stran účtovat žádné částky za hodnocený léčivý přípravek nebo srovnávací lék ani za jakékoliv služby, které mu podle této smlouvy proplácí zadavatel nebo subjekt jím určený.

Payment for Sponsor Drug or Comparator Drug. Institution and Principal Investigator will not charge a Trial Subject or third-party payer for Sponsor Drug or Comparator Drug or for any services reimbursed by Sponsor or its designee under this Agreement. 4.5. Platba za hodnocený léčivý přípravek nebo srovnávací lék. Zdravotnické zařízení a hlavní zkoušející nebudou subjektům klinického hodnocení ani plátcům třetích stran účtovat žádné částky za hodnocený léčivý přípravek nebo srovnávací lék ani za jakékoliv služby, které mu podle této smlouvy proplácí zadavatel nebo jeho zástupce.

Payment for Sponsor Drug or Comparator Drug. Institution and Principal Investigator will not charge a Trial Subject or third-party payer or national payer for Sponsor Drug or Comparator Drug or for any services reimbursed by Sponsor or its designee under this Agreement. 4.5.

Payment for Sponsor Drug or Comparator Drug. Institution and Principal Investigator will not charge a Trial Subject or third-party payer for Sponsor Drug or Comparator Drug or for any services reimbursed by Sponsor or its designee under this Agreement. 4.5.

Payment for Sponsor Drug or Comparator Drug. Institution and Principal Investigator will not charge a Trial Subject or third-party payer for Sponsor Drug or Comparator Drug or for any services reimbursed by Sponsor or its designee under this Agreement. 4.5. Platba za hodnocený léčivý přípravek nebo srovnávací lék Zdravotnické zařízení a hlavní zkoušející nebudou subjektům klinického hodnocení ani plátcům třetích stran účtovat žádné částky za hodnocený léčivý přípravek nebo srovnávací lék ani za jakékoliv služby, které mu podle této smlouvy proplácí zadavatel.

Payment for Sponsor Drug or Comparator Drug. Institution Provider and Principal Investigator will not charge a Trial Subject or third-party payer for Sponsor Drug or Comparator Drug or for any services reimbursed by Sponsor or its designee under this Agreement. 4.55.

Payment for Sponsor Drug or Comparator Drug. Institution and Principal Investigator will not charge a Trial Subject or third-party payer for Sponsor Drug or Comparator Drug or for any services reimbursed by Sponsor or its designee under this Agreement. 4.55.

Payment for Sponsor Drug or Comparator Drug. Institution and Principal Investigator will not charge a Trial Subject or third-party payer for Sponsor Drug or Comparator Drug or for any services reimbursed by Sponsor or its designee under this Agreement. 4.55.

Payment for Sponsor Drug or Comparator Drug. Institution and Principal Investigator Provider will not charge a Trial Subject or third-party payer for Sponsor Drug or Comparator Drug or for any services reimbursed by Sponsor or its designee under this Agreement. 4.55.

Payment for Sponsor Drug or Comparator Drug. Institution and Principal Investigator will not charge a Trial Subject or third-party payer for Sponsor Drug or Comparator Drug or for any services reimbursed by Sponsor or its designee under this Agreement. 4.55.

Payment for Sponsor Drug or Comparator Drug. Institution and Principal Investigator will not charge a Trial Subject or third-party payer for Sponsor Drug or Comparator Drug or for any services reimbursed by Sponsor or its designee under this Agreement. 4.55.

Payment for Sponsor Drug or Comparator Drug. Institution and Principal Investigator will not charge a Trial Subject or third-party payer for Sponsor Drug or Comparator Drug or for any services reimbursed by Sponsor or its designee under this Agreement. 4.5. Platba za hodnocený léčivý přípravek nebo srovnávací lék. Zdravotnické zařízení a hlavní zkoušející nebudou subjektům klinického hodnocení ani plátcům třetích stran účtovat žádné částky za hodnocený léčivý přípravek nebo srovnávací lék ani 5.

Payment for Sponsor Drug or Comparator Drug. Institution and Principal Investigator will not charge a Trial Subject or third-party payer for Sponsor Drug or Comparator Drug or for any services reimbursed by Sponsor or its designee under this Agreement. 4.54.6.

Payment for Sponsor Drug or Comparator Drug. Institution Provider and Principal Investigator will not charge a Trial Subject or third-party payer for Sponsor Drug or Comparator Drug or for any services reimbursed by Sponsor or its designee under this Agreement. 4.55.

Payment for Sponsor Drug or Comparator Drug. Institution and Principal Investigator will not charge a Trial Subject or third-party payer for Sponsor Drug or Comparator Drug or for any services reimbursed by Sponsor or its designee under this Agreement. 4.56.

Payment for Sponsor Drug or Comparator Drug. Institution and Principal Investigator will not charge a Trial Subject or third-third- party payer for Sponsor Drug or Comparator Drug or for any services reimbursed by Sponsor or its designee under this Agreement. 4.55.

Payment for Sponsor Drug or Comparator Drug. Institution Provider and Principal Investigator will not charge a Trial Subject or third-party payer for Sponsor Drug or Comparator Drug or for any services reimbursed by Sponsor or its designee under this Agreement. 4.56.

Payment for Sponsor Drug or Comparator Drug. Institution and Principal Investigator will not charge a Trial Subject subject or third-party payer for Sponsor Drug or Comparator Drug or for any services reimbursed by Sponsor or its designee under this Agreement. 4.5.5.5

Payment for Sponsor Drug or Comparator Drug. Institution and Principal Investigator will not charge a Trial Subject or third-third- party payer for Sponsor Drug or Comparator Drug or for any services reimbursed by Sponsor or its designee under this Agreement. 4.5.5.5

Payment for Sponsor Drug or Comparator Drug. Institution and Principal Investigator will not charge a Trial Subject or third-party payer for Sponsor Drug or Comparator Drug or for any services reimbursed by Sponsor or its designee under this Agreement. 4.5.5.5